Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $213.33
Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given a consensus recommendation of “Hold” by the thirty research firms that are covering the stock, Marketbeat reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price target among brokerages […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given a consensus recommendation of “Hold” by the thirty research firms that are covering the stock, Marketbeat reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price target among brokerages […]
